GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (OTCPK:ROSGQ) » Definitions » FCF Margin %

Rosetta Genomics (Rosetta Genomics) FCF Margin % : 0.00% (As of Jun. 2017)


View and export this data going back to 2007. Start your Free Trial

What is Rosetta Genomics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rosetta Genomics's Free Cash Flow for the three months ended in Jun. 2017 was $0.00 Mil. Rosetta Genomics's Revenue for the three months ended in Jun. 2017 was $0.87 Mil. Therefore, Rosetta Genomics's FCF Margin % for the quarter that ended in Jun. 2017 was 0.00%.

As of today, Rosetta Genomics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Rosetta Genomics's FCF Margin % or its related term are showing as below:

ROSGQ' s FCF Margin % Range Over the Past 10 Years
Min: -208.1   Med: 0   Max: 0
Current: -208.1

ROSGQ's FCF Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -11.09 vs ROSGQ: -208.10

Rosetta Genomics FCF Margin % Historical Data

The historical data trend for Rosetta Genomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rosetta Genomics FCF Margin % Chart

Rosetta Genomics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,431.34 -2,773.83 -1,043.63 -208.10 -114.68

Rosetta Genomics Quarterly Data
Dec10 Mar11 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Jun17
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rosetta Genomics's FCF Margin %

For the Diagnostics & Research subindustry, Rosetta Genomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's FCF Margin % falls into.


Rosetta Genomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rosetta Genomics's FCF Margin for the fiscal year that ended in Dec. 2016 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-10.59/9.234
=-114.68 %

Rosetta Genomics's FCF Margin for the quarter that ended in Jun. 2017 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2017 )/Revenue (Q: Jun. 2017 )
=0/0.87
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (OTCPK:ROSGQ) » Definitions » FCF Margin %
Comparable Companies
BOM:526504 TSXV:MBI.H TEAR TSXV:AVCR NGM:LIFE B BOM:526546 BOM:541299 ASX:CTE TSXV:TELO ASX:LSH IDTA XSAT:ALPH BOM:526301 ABMC XLRM WAR:BMX XKRX:271850 WAR:IGN BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
10 Plaut Street, Science Park, Rehovot, ISR, 76706
Website
http://www.rosettagenomics.com
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.
Executives
Sabby Management, Llc 10 percent owner 115 HIDDEN HILLS DR, SPICEWOOD TX 78669
Sabby Healthcare Volatility Master Fund, Ltd. 10 percent owner C/O SABBY MANAGEMENT, LLC, 10 MOUNTAINVIEW ROAD, SUITE 205, UPPER SADDLE RIVER NJ 07458